KRTX logo

Karuna Therapeutics (KRTX) EBITDA

Annual EBITDA

-$493.08 M
-$204.51 M-70.87%

December 31, 2023

Summary

Performance

1-Year Change

-70.87%

3-Year Change

-621.23%

5-Year Change

-3204.13%

15-Year Change

-10045.6%

KRTX EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

-$4.86 M

3-Year Low

-$493.08 M
KRTX annual EBITDA is currently at its 3-year low

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2023
KRTX previous annual earnings announcement was published on Dec 31, 2023

Next Annual Earnings Report Date

N/A
KRTX next annual earnings announcement has not yet been scheduled

OtherKRTXprofitabilitymetrics:

Annual Revenue

$654.00 K
KRTX annual revenue is $654.00 thousand

Annual Net Income

-$433.68 M
KRTX annual net profit is -$433.68 million

Annual EBIT

-$494.78 M
KRTX annual earnings before interest & taxes is -$494.78 million

Annual EPS

-$11.73
KRTX annual earnings per share is -$11.73

Quarterly EBITDA

-$129.14 M
+$6.62 M+4.88%

December 31, 2023

Summary

Performance

3-Month Change

+4.88%

1-Year Change

+4.88%

3-Year Change

+4.88%

5-Year Change

+4.88%

KRTX Quarterly EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

-$146.00 K

3-Year Low

-$135.76 M

Earnings dates

Last Quarterly Earnings Report Date

Dec 31, 2023
KRTX previous earnings announcement was published on Dec 31, 2023

Next Quarterly Earnings Report Date

N/A
KRTX next earnings announcement has not yet been scheduled

OtherKRTXprofitabilitymetrics:

Quarterly Revenue

-
KRTX quarterly revenue value is unknown

Quarterly Net Income

-$113.82 M
KRTX quarterly net profit is -$113.82 million

Quarterly EBIT

-$129.59 M
KRTX quarterly earnings before interest & taxes is -$129.59 million

Quarterly EPS

-$3.01
KRTX quarterly earnings per share is -$3.01

TTM EBITDA

-$493.08 M
-$44.41 M-9.90%

December 31, 2023

Summary

Performance

3-Month Change

-9.9%

1-Year Change

-9.9%

3-Year Change

-9.9%

5-Year Change

-9.9%

KRTX TTM EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

-$1.54 M

3-Year Low

-$493.08 M
KRTX TTM EBITDA is currently at its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Dec 31, 2023
KRTX previous earnings announcement was published on Dec 31, 2023

Next Quarterly Earnings Report Date

N/A
KRTX next earnings announcement has not yet been scheduled

OtherKRTXprofitabilitymetrics:

TTM Revenue

-
KRTX TTM revenue value is unknown

TTM Net Income

-$433.68 M
KRTX TTM net profit is -$433.68 million

TTM EBIT

-$494.78 M
KRTX TTM earnings before interest & taxes is -$494.78 million

TTM EPS

-$11.72
KRTX TTM earnings per share is -$11.72

EBITDA Formula

EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization

Annual EBITDA

-$493.08 M
KRTX annual EBITDA is -$493.08 million

Annual Net Income

-$433.68 M
KRTX annual net profit is -$433.68 million

Annual Interest Expense

-
KRTX annual interest expense value is unknown

Annual Income Tax

$670.00 K
KRTX annual income tax is $670.00 thousand

Annual D&A

$1.70 M
KRTX annual depreciation & amortization is $1.70 million

KRTX EBITDA Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-70.9%+4.9%-9.9%
3 y3 years-621.2%+4.9%-9.9%
5 y5 years-3204.1%+4.9%-9.9%

KRTX EBITDA Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year+244.0%at low+362.0%+5.1%+244.0%at low
5 y5-year+1047.9%at low+1565.7%+5.1%+1090.5%at low
alltimeall time>+9999.0%at low>+9999.0%+5.1%>+9999.0%at low

Karuna Therapeutics EBITDA History

DateAnnualQuarterlyTTM
Dec 2023
-$493.08 M(+70.9%)
-$129.14 M(-4.9%)
-$493.08 M(+9.9%)
Sep 2023
-
-$135.76 M(+13.7%)
-$448.67 M(+14.0%)
Jun 2023
-
-$119.44 M(+9.8%)
-$393.61 M(+16.1%)
Mar 2023
-
-$108.74 M(+28.3%)
-$338.96 M(+17.5%)
Dec 2022
-$288.56 M(+101.3%)
-$84.73 M(+5.0%)
-$288.56 M(+24.5%)
Sep 2022
-
-$80.70 M(+24.6%)
-$231.79 M(+14.7%)
Jun 2022
-
-$64.78 M(+11.0%)
-$202.15 M(+17.6%)
Mar 2022
-
-$58.35 M(+108.7%)
-$171.84 M(+19.9%)
Dec 2021
-$143.35 M(+109.7%)
-$27.95 M(-45.3%)
-$143.35 M(+5.1%)
Sep 2021
-
-$51.06 M(+48.1%)
-$136.45 M(+30.1%)
Jun 2021
-
-$34.48 M(+15.5%)
-$104.87 M(+18.9%)
Mar 2021
-
-$29.85 M(+41.8%)
-$88.18 M(+29.0%)
DateAnnualQuarterlyTTM
Dec 2020
-$68.37 M(+59.2%)
-$21.05 M(+8.0%)
-$68.37 M(+24.2%)
Sep 2020
-
-$19.49 M(+9.5%)
-$55.06 M(+23.5%)
Jun 2020
-
-$17.79 M(+77.3%)
-$44.60 M(+7.7%)
Mar 2020
-
-$10.03 M(+29.4%)
-$41.42 M(-3.6%)
Dec 2019
-$42.95 M(+187.8%)
-$7.75 M(-14.1%)
-$42.95 M(-0.9%)
Sep 2019
-
-$9.02 M(-38.2%)
-$43.33 M(+10.5%)
Jun 2019
-
-$14.61 M(+26.2%)
-$39.22 M(+58.4%)
Mar 2019
-
-$11.57 M(+42.3%)
-$24.76 M(+68.1%)
Dec 2018
-$14.92 M(+207.1%)
-$8.13 M(+65.5%)
-$14.73 M(+123.2%)
Sep 2018
-
-$4.91 M(+3265.8%)
-$6.60 M(+291.6%)
Jun 2018
-
-$146.00 K(-90.5%)
-$1.69 M(+9.5%)
Mar 2018
-
-$1.54 M
-$1.54 M
Dec 2017
-$4.86 M
-
-

FAQ

  • What is Karuna Therapeutics annual EBITDA?
  • What is the all time high annual EBITDA for Karuna Therapeutics?
  • What is Karuna Therapeutics annual EBITDA year-on-year change?
  • What is Karuna Therapeutics quarterly EBITDA?
  • What is the all time high quarterly EBITDA for Karuna Therapeutics?
  • What is Karuna Therapeutics quarterly EBITDA year-on-year change?
  • What is Karuna Therapeutics TTM EBITDA?
  • What is the all time high TTM EBITDA for Karuna Therapeutics?
  • What is Karuna Therapeutics TTM EBITDA year-on-year change?

What is Karuna Therapeutics annual EBITDA?

The current annual EBITDA of KRTX is -$493.08 M

What is the all time high annual EBITDA for Karuna Therapeutics?

Karuna Therapeutics all-time high annual EBITDA is -$4.86 M

What is Karuna Therapeutics annual EBITDA year-on-year change?

Over the past year, KRTX annual EBITDA has changed by -$204.51 M (-70.87%)

What is Karuna Therapeutics quarterly EBITDA?

The current quarterly EBITDA of KRTX is -$129.14 M

What is the all time high quarterly EBITDA for Karuna Therapeutics?

Karuna Therapeutics all-time high quarterly EBITDA is -$146.00 K

What is Karuna Therapeutics quarterly EBITDA year-on-year change?

Over the past year, KRTX quarterly EBITDA has changed by +$6.62 M (+4.88%)

What is Karuna Therapeutics TTM EBITDA?

The current TTM EBITDA of KRTX is -$493.08 M

What is the all time high TTM EBITDA for Karuna Therapeutics?

Karuna Therapeutics all-time high TTM EBITDA is -$1.54 M

What is Karuna Therapeutics TTM EBITDA year-on-year change?

Over the past year, KRTX TTM EBITDA has changed by -$44.41 M (-9.90%)